The U.S. academic medical centers market size is expected to reach USD 1,983.2 billion by 2033, registering a CAGR of 7.8% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market's growth can be attributed to better access to the latest breakthroughs and treatment procedures and the launch of new AMCs in the U.S.
Academic Medical Centers (AMCs) are rapidly shifting towards the latest technologies and treatment models owing to the rising research funding from the federal government. For instance, in May 2022, the University of Maryland School of Medicine partnered with University of Maryland College Park (UMCP) computer scientists, engineers, and University of Michigan physician-scientists to launch MIXR, a new Center for Medical Innovations in Extended Reality. Such initiatives by the major facilities are expected to drive the market's growth over the forecast period.
The COVID-19 pandemic has negatively impacted the market's growth during the initial phase, owing to reduced patient demand and closures of research operations at these centers to limit the spread of the virus. Moreover, medical education was significantly impacted. Many medical schools had to transition to virtual or hybrid learning models, disrupting traditional in-person clinical rotations and hands-on training. However, the pandemic accelerated the adoption of telemedicine and virtual care models. Academic medical centers had to quickly implement telehealth solutions to continue providing patient care while minimizing in-person interactions. This shift prompted a reconsideration of healthcare delivery models.
Request a free sample copy or view report summary: U.S. Academic Medical Centers Market Report
Based on ownership, the private AMC segment held the largest revenue share of 56.3% in 2025. The public AMC segment accounted for a substantial share of the market in 2025 and is expected to grow steadily over the forecast period.
Based on the therapeutic area, the oncology segment held a significant share of 24.9% in 2025. The cardiovascular diseases segment is expected to grow at a significant CAGR of 8.6% during the forecast period.
Based on bed capacity, the more than 800 beds segment held a significant share of 42.5% in 2025. The less than 300 beds segment is expected to grow to a significant CAGR during the forecast period.
The Northeast dominated the market in 2025, accounting for the largest revenue share of 31.0%. The Southwest is expected to register the fastest CAGR of 8.0% during the forecast period.
Grand View Research has segmented U.S. academic medical center market report based on ownership, therapeutic area, bed capacity, and region:
U.S. Academic Medical Centers Ownership Outlook (Revenue, USD Million, 2021 - 2033)
Public Academic Medical Centers
Private Academic Medical Centers
U.S. Academic Medical Centers Therapeutic area Outlook (Revenue, USD Million, 2021 - 2033)
Oncology
Cardiovascular Diseases
Neurology & Neurosciences
Orthopedics
Gastroenterology
Others
U.S. Academic Medical Centers Bed Capacity Outlook (Revenue, USD Million, 2021 - 2033)
Less than 300 Beds
300-500 Beds
501-800 Beds
More than 800 Beds
U.S. Academic Medical Centers Region Outlook (Revenue, USD Million, 2021 - 2033)
Northeast
Southeast
Southwest
Midwest
West
List of Key Players of U.S. Academic Medical Centers Market
Cleveland Clinic
Weill Cornell Medicine
Vanderbilt University Medical Center
University Hospitals
The General Hospital Corporation (Massachusetts General Hospital)
Stanford Health Care
UAB Health System
Mayo Foundation for Medical Education and Research (Mayo Clinic)
Icahn School of Medicine at Mount Sinai
Cedars-Sinai
Johns Hopkins University
UC San Diego Health
"The quality of research they have done for us has been excellent..."